Symptoms and Infections: How the Condition Shows Up

Because Immunodeficiency 89 (IMD89) is a “combined” immunodeficiency, it affects how your child’s body defends itself against a wide variety of threats. The way this condition shows up—the clinical presentation—can vary depending on which specific mutation your child has. While some children experience severe, life-threatening infections early in life, others may have more subtle signs of an immune system that is “misregulated” rather than completely absent ^[1][2].

Common Infection Patterns

Many children with IMD89 struggle with recurrent infections. These usually fall into two categories:

1. Sinopulmonary Infections: These are typical “childhood” infections of the sinuses, ears, and lungs (like pneumonia) caused by common bacteria ^[1][2]. However, in a child with IMD89, these infections may happen more often, last longer, or require multiple rounds of antibiotics to clear.
2. Opportunistic Infections: These are infections caused by germs that usually don’t make healthy people sick. A finding in some children with severe IKZF3 mutations (like p.Asn160Ser) is Pneumocystis jirovecii pneumonia (PJP) ^[3]. PJP is a type of fungal lung infection that can be a sign that the T cells—the “commanders” of the immune system—are not working correctly ^[3]. It is not specific to IKZF3, but rather a sign of impaired cellular immunity.

Early Warning Signs: Growth and Digestion

For many families, the first clues that something is wrong aren’t just infections, but how the child is growing.

• Failure to Thrive (Poor Weight Gain): This is a medical term used when a child’s weight or rate of weight gain is significantly below that of other children of the same age and sex ^[4]. In IMD89, the body may be spending so much energy fighting off constant low-grade infections that it doesn’t have enough left for growth.
• Chronic Diarrhea: Some children experience frequent, loose stools that don’t go away ^[4]. While this can be caused by an infection, medication side effects, or malabsorption, preliminary research in animal models proposes a hypothesis that the IKZF3 mutation might make the intestines prone to inflammation ^[5]. This is an area of ongoing study, not an established human diagnosis.

Immune Dysregulation vs. Autoimmunity

It is helpful to understand the difference between two terms your doctors might use: immune dysregulation and autoimmunity.

• Immune Dysregulation: This is a broad term meaning the immune system is “out of tune.” The cells are not developing correctly, they are in the wrong places, or they are sending the wrong signals ^[1]. This is a defining feature of IMD89. It can lead to things like lymphadenopathy (swollen lymph nodes) or splenomegaly (an enlarged spleen) as the body tries to manage its “confused” immune cells ^[2].
• Autoimmunity: This is a specific type of dysregulation where the immune system mistakenly attacks the body’s own healthy tissues, such as in lupus or rheumatoid arthritis. While some patients with specific variants of IMD89 have shown signs of autoimmunity or allergies, it is not a universal feature for every child with this diagnosis ^[1][2].

Monitoring for the Future

Because the immune system is not maturing correctly, there is a theoretical risk that “confused” cells could eventually become cancerous. In some families, adult members have developed Chronic Lymphocytic Leukemia (CLL) or lymphoma ^[3][6]. While this observation has been made, the magnitude of risk is unknown and there is no validated IKZF3-specific screening schedule. Your medical team will monitor your child’s blood counts and lymph nodes very closely over the long term, avoiding unnecessary anxiety while ensuring any changes are identified early.